Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000049637 | SCV001401298 | pathogenic | Non-ketotic hyperglycinemia | 2023-03-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 56225). This variant has been observed in individual(s) with glycine encephalopathy (PMID: 19299230, 27362913). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant occurs in a non-coding region of the AMT gene. It does not change the encoded amino acid sequence of the AMT protein. |
Myriad Genetics, |
RCV000049637 | SCV002060041 | uncertain significance | Non-ketotic hyperglycinemia | 2021-11-18 | criteria provided, single submitter | clinical testing | NM_000481.3(AMT):c.-55C>T is a non coding variant classified as a variant of uncertain significance in the context of glycine encephalopathy, AMT-related. c.-55C>T has been observed in cases with relevant disease (PMID: 27362913, 19299230). Functional assessments of this variant are not available in the literature. c.-55C>T has been observed in population frequency databases (gnomAD: OTH 0.017%). In summary, there is insufficient evidence to classify NM_000481.3(AMT):c.-55C>T as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. |
Centre de Biologie Pathologie Génétique, |
RCV002273949 | SCV002558909 | pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing | ||
Baylor Genetics | RCV000049637 | SCV004196841 | pathogenic | Non-ketotic hyperglycinemia | 2023-03-11 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049637 | SCV000082044 | probable-pathogenic | Non-ketotic hyperglycinemia | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |